178 related articles for article (PubMed ID: 8477090)
21. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
Robbins JD; Robbins JB
J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid fever.
Tran Vu Thieu N; Trinh Van T; Tran Tuan A; Klemm EJ; Nguyen Ngoc Minh C; Voong Vinh P; Pham Thanh D; Ho Ngoc Dan T; Pham Duc T; Langat P; Martin LB; Galan J; Liang L; Felgner PL; Davies DH; de Jong HK; Maude RR; Fukushima M; Wijedoru L; Ghose A; Samad R; Dondorp AM; Faiz A; Darton TC; Pollard AJ; Thwaites GE; Dougan G; Parry CM; Baker S
J Infect; 2017 Aug; 75(2):104-114. PubMed ID: 28551371
[TBL] [Abstract][Full Text] [Related]
23. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.
Roggelin L; Vinnemeier CD; Fischer-Herr J; Johnson-Weaver BT; Rolling T; Burchard GD; Staats HF; Cramer JP
Vaccine; 2015 Aug; 33(33):4141-5. PubMed ID: 26144902
[TBL] [Abstract][Full Text] [Related]
24. Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
Ahmadi H; Tabaraie B; Maleknia S; Shapouri R; Nejati M; Pour Mirza Gholi F; Hedayati M; Sadati M; Zahednia S; Sharifat Salmani A
J Med Microbiol; 2013 Feb; 62(Pt 2):283-286. PubMed ID: 23105026
[TBL] [Abstract][Full Text] [Related]
25. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
Acharya IL; Lowe CU; Thapa R; Gurubacharya VL; Shrestha MB; Cadoz M; Schulz D; Armand J; Bryla DA; Trollfors B
N Engl J Med; 1987 Oct; 317(18):1101-4. PubMed ID: 3657877
[TBL] [Abstract][Full Text] [Related]
26. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.
Sánchez-Ramón S; de Gracia J; García-Alonso AM; Rodríguez Molina JJ; Melero J; de Andrés A; García Ruiz de Morales JM; Ferreira A; Ocejo-Vinyals JG; Cid JJ; García Martínez JM; Lasheras T; Vargas ML; Gil-Herrera J; García Rodríguez MC; Castañer JL; González Granado LI; Allende LM; Soler-Palacin P; Herráiz L; López Hoyos M; Bellón JM; Silva G; Gurbindo DM; Carbone J; Rodríguez-Sáinz C; Matamoros N; Parker AR; Fernández-Cruz E;
Clin Immunol; 2016 Aug; 169():80-84. PubMed ID: 27236002
[No Abstract] [Full Text] [Related]
27. Production of monoclonal antibodies to Vi polysaccharide antigen of Salmonella typhi.
Pongsunk S; Sarasombath S; Ekpo P; Tangtherawattana P; Levine MM
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):53-6. PubMed ID: 8216560
[TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
Tacket CO; Ferreccio C; Robbins JB; Tsai CM; Schulz D; Cadoz M; Goudeau A; Levine MM
J Infect Dis; 1986 Aug; 154(2):342-5. PubMed ID: 2425009
[No Abstract] [Full Text] [Related]
29. Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity.
Parker AR; Bradley C; Harding S; Sánchez-Ramón S; Jolles S; Kiani-Alikhan S
J Immunol Methods; 2018 Aug; 459():1-10. PubMed ID: 29800575
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of purified Vi polysaccharide typhoid vaccine.
Park JH; Hong JJ; Choi ES; Lee JW; Park JH
J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
[TBL] [Abstract][Full Text] [Related]
31. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
[No Abstract] [Full Text] [Related]
32. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.
Singh M; Ganguly NK; Kumar L; Vohra H
Microbiol Immunol; 1999; 43(6):535-42. PubMed ID: 10480549
[TBL] [Abstract][Full Text] [Related]
33. Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses.
Bhuiyan MS; Kalsy A; Arifuzzaman M; Charles RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
Am J Trop Med Hyg; 2020 Sep; 103(3):1032-1038. PubMed ID: 32720632
[TBL] [Abstract][Full Text] [Related]
34. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
[TBL] [Abstract][Full Text] [Related]
36. The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen.
Marshall JL; Flores-Langarica A; Kingsley RA; Hitchcock JR; Ross EA; López-Macías C; Lakey J; Martin LB; Toellner KM; MacLennan CA; MacLennan IC; Henderson IR; Dougan G; Cunningham AF
J Immunol; 2012 Dec; 189(12):5527-32. PubMed ID: 23162127
[TBL] [Abstract][Full Text] [Related]
37. S.Typhi derived OmpC peptide conjugated with Vi-polysaccharide evokes better immune response than free Vi-polysaccharide in mice.
Haque S; Sengupta S; Gupta D; Bhan MK; Kumar R; Khan A; Jailkhani B
Biologicals; 2019 Nov; 62():50-56. PubMed ID: 31606267
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
[TBL] [Abstract][Full Text] [Related]
39. Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi.
Belde V; Cravens MP; Gulandijany D; Walker JA; Palomo-Caturla I; Alugupalli AS; Sandilya VK; Mahmoud T; Bäumler AJ; Kearney JF; Alugupalli KR
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967094
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the immunogenicity and safety of two different brands of Salmonella typhi Vi capsular polysaccharide vaccine.
Sabitha P; Prabha Adhikari MR; Chowdary A; Prabhu M; Soofi M; Shetty M; Kamath A; Lokaranjan SS; Bangera SS
Indian J Med Sci; 2004 Apr; 58(4):141-9. PubMed ID: 15122049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
